[Macular infarction after intravitreal injection of amikacin: case report].
The authors report a case of a patient who underwent cataract surgery with implantation of a posterior chamber intraocular lens and presented endophthalmitis on the second postoperative day. She was treated with intravitreal injection of amikacin, vancomycin and dexamethasone. After resolution of the infection the patient presented macular infarction and important loss of visual acuity due to amikacin toxicity.
Almeida
Luciana Negrão Frota de
LN
Clínica de Olhos do Pará, e Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, MG. lucianaalmeida@realizanet.com.br
Canêdo
Miguel Gustavo Rosa da Rocha
MG
Almeida
Rafael Negrão Frota de
RN
Almeida Sobrinho
Edmundo Frota de
EF
Nehemy
Márcio Bittar
MB
D000328:Adult; D000583:Amikacin / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D009877:Endophthalmitis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007238:Infarction / Q000139:chemically induced* / Q000175:diagnosis; D015552:Injections, Intralesional; D008266:Macula Lutea / Q000098:blood supply*; D018918:Phacoemulsification / Q000009:adverse effects; D014640:Vancomycin / Q000009:adverse effects; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000583:Amikacin